NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.860
-0.070 (-3.63%)
At close: Feb 27, 2026, 4:00 PM EST
1.863
+0.003 (0.16%)
After-hours: Feb 27, 2026, 7:28 PM EST
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $59.28 million as of February 27, 2026. Its market cap has increased by 66.52% in one year.
Market Cap
59.28M
Enterprise Value
62.35M
1-Year Change
66.52%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has decreased from $65.80M to $59.28M, a decrease of -9.90%. That is a compound annual growth rate of -1.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 52.30M | -31.27% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 63.74M |
| InflaRx | 62.41M |
| NeurAxis | 62.00M |
| Alterity Therapeutics | 61.77M |
| TScan Therapeutics | 61.00M |
| Spruce Biosciences | 60.19M |
| ImmuCell | 58.84M |
| Instil Bio | 58.39M |